The Photosensitizing Clinical Agent Verteporfin is an Inhibitor of SPAK and OSR1 Kinases

Luke Alderwick, Mark Jeeves

Research output: Contribution to journal › Article › peer-review

9 Citations (Scopus)

183 Downloads (Pure)

1 results

Finished
MRC CIC - Discovery of small molecule MO25-binders as novel treatments for resistant hypertension
Mehellou, Y., Alderwick, L., Martin, U. & Simpkins, N.
Medical Research Council
1/08/15 → 30/11/16
Project: Research Councils